Austrianova

Austrianova Austrianova is a high tech, life science and biotech company with a global footprint that encapsulates living cells in bio-inert polymers

Austrianova CPO, Rahul Pawa, was invited to TISTR International Conference 2026.
09/06/2026

Austrianova CPO, Rahul Pawa, was invited to TISTR International Conference 2026.

21/05/2026

Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy

Austrianova management were invited guests at todays event "Supercharging Healthspan and Joyspan: the State-of-Art Longe...
19/05/2026

Austrianova management were invited guests at todays event "Supercharging Healthspan and Joyspan: the State-of-Art Longevity Technology and Therapeutics” held at The Meeting Point @ JTC LaunchPad. The event featured a session on Start Ups and investment opportunities as well as sessions on Women’s Health and Men’s Health.

We welcome Thomas to our Board!
23/04/2026

We welcome Thomas to our Board!

SINGAPORE - April 21, 2026 - SG Austria/Austrianova (the SG Austria group comprising of Austrianova Singapore, Austrianova Thailand and Anovade UG) (the “Company”) is pleased to announce the appointment of C. Thomas Paschall, CEO and Founder of Checkmate Capital, to the Board of the SG Austria g...

Austrianova and AVAI Bio at the forefront of cell-based therapies for anti-aging and longevity using Cell-in-a-Box encap...
22/04/2026

Austrianova and AVAI Bio at the forefront of cell-based therapies for anti-aging and longevity using Cell-in-a-Box encapsulation

From encapsulated cell therapies to gene-driven breakthroughs, a new wave of biotech is targeting the biology of aging.

https://www.stocktitan.net/news/AVAI/"Recent news has highlighted Avant’s joint venture with SGAustria Pte. Ltd. to form...
08/04/2026

https://www.stocktitan.net/news/AVAI/

"Recent news has highlighted Avant’s joint venture with SGAustria Pte. Ltd. to form Insulinova, Inc., which is intended to develop cell-based therapies for type 1 and some insulin-dependent type 2 diabetes using insulin-producing cells combined with encapsulation technology. Other announcements cover the creation and progress of Klothonova, a 50/50 joint venture with Austrianova that is developing encapsulated Klotho-producing cell therapies for age-related conditions, including cardiovascular and neurodegenerative diseases."

Read the latest AVAI news on Avant Technologies, including joint ventures for diabetes and Klotho therapies, AI-based Vision AI updates, and corporate actions. Latest AVAI news updated today, April 7.

Austrianova wishes every a Happy G🐰🐰d Friday!
03/04/2026

Austrianova wishes every a Happy G🐰🐰d Friday!

Selamat Hari Raya Aidilfitri from all of us, Austrianova
20/03/2026

Selamat Hari Raya Aidilfitri from all of us, Austrianova

Austrianova Germany's accounting colleagues visited Austrianova Headquarters in Singapore today.
06/03/2026

Austrianova Germany's accounting colleagues visited Austrianova Headquarters in Singapore today.

Austrianova wishes everyone a Gall🍊ping & Pr🍊sper🍊us Lunar New Year!
16/02/2026

Austrianova wishes everyone a Gall🍊ping & Pr🍊sper🍊us Lunar New Year!

Address

2 International Business Park, The Strategy @ IBP, #09/04
Jurong East
609930

Alerts

Be the first to know and let us send you an email when Austrianova posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share